Thesis Overview
- Composed of two main parts
- Short mid-field magnets
- Magnetic Particle Imaging (MPI) for functional neuroimaging
Part 1: Short Mid-Field Magnets
- Aim: Develop shorter and more open magnets to reduce claustrophobia and enhance patient comfort
- Key Topics:
- Extended scaling relations for superconducting MRI magnets
- Hybrid designs for shortening MRI magnets
Importance of Short Magnets
- Patients often suffer from claustrophobia leading to
- Cancelled scans
- Increased costs for medical facilities
- Mid-field magnets are more compatible with metallic implants compared to conventional higher-field systems (1.5T & 3T)
- Lower installation costs and operational costs for hospitals
Components of MRI Systems:
- Static Viscera Field: Determines the Larmor frequency and magnetizes tissue spins.
- Gradient Coils
- Radio Coils
- Focus on magnet design, emphasizing homogeneity=
- Perfect homogeneity = 0, ideally close to 1 PPM deviation in clinical settings, but real-world deviations reach about 500 PPM.
Design Approaches
- Types of magnets: Superconducting, resistive, and permanent magnets
- Main questions:
- What are the limits on superconducting designs?
- Can hybrid designs using all three magnet types provide shorter configurations?
Optimization Frameworks for Magnet Design
- Scaling relation: Optimal magnet length relates to diameter and imaging region size
- Extended parameters via optimization studies allow for new configurations
Aims of Part 1
Extended Scaling Relations:
- Expanded parameter space improves flexibility in magnet design
- Example scaling relations compare properties for spherical vs. ellipsoidal regions of interest.
Hybrid Designs:
- Integration of superconducting windings with rare earth materials leads to greater field homogeneity
- Experimental observations indicate a possible 20% size reduction for mid-field MRI systems
Part 2: Magnetic Particle Imaging for Functional Neuroimaging
- Focus on measuring local intensity changes in the brain based on activation patterns
- Dual objectives:
- Apply functional MPI in human studies via primate models
- Measure peripheral nerve stimulation safety during MPI operations
Functional Neuroimaging Overview
- Measures the cerebral blood volume (CBV) responding to stimuli, to identify brain areas activated by tasks
- Critical differences between fMRI and MPI:
- fMRI depends on physiological responses, MPI directly measures blood volume changes, potentially offering clearer results
Tools for Functional Neuroimaging
- Traditional methods (e.g., fMRI) struggle with physiological noise and limited sensitivity in clinical diagnostics
- MPI advantages:
- High contrast-to-noise ratio due to lack of background signals
- Non-ionizing and safe for human use
Principles of MPI
- Involves injecting superparamagnetic iron oxide nanoparticles (SPIONs)
- AC magnetic fields cause SPIONS to fluctuate magnetization, producing measurable signals via receive coils
Human Scale MPI Scanner
- Features
- 7mm spatial resolution, high-speed imaging (2 images in 10 seconds)
- Mechanical and electrical system details
Experimental Protocols for MPI
- Tests conducted on primates to validate feasibility in humans:
- Injection of tracer, followed by hypercapnia experiments
- Data processing exercises: stabilization of noisy signals, generating activation maps showing brain regions responding to stimulus with success rates of up to 6 times better than fMRI
Safety Measurements
- Concerns regarding peripheral nerve stimulation from time-varying fields
- Development of thresholds for stimulation at multiple frequencies to ensure safety
- Comparative study identifies deviations from established models when operating above 10 kHz
Conclusion
- MPI presents a promising functional neuroimaging tool with direct blood volume measurement capabilities
- Future improvements necessary for spion tracers, including safety and performance optimizations.
- Need for thorough investigations of nerve stimulation implications at high frequencies.
Future Directions
- Investigate advanced imaging techniques for better clinical utility.
- Ensure regulatory approval for clinical tracers.
- Ongoing assessment of the MPI system's safety characteristics for human usage.